Skip to main content

Table 1 Association of the TS score with somatic variants

From: Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma

Gene symbol

High TS score (%)

Low TS score (%)

p value

TP53

113 (54%)

76 (39%)

0.0028

TTN

84 (40%)

76 (39%)

0.8393

KMT2D

59 (28%)

43 (22%)

0.1697

MUC16

48 (23%)

49 (25%)

0.6421

ARID1A

52 (25%)

45 (23%)

0.7270

KDM6A

36 (17%)

53 (27%)

0.0167

PIK3CA

42 (20%)

41 (21%)

0.9020

SYNE1

33 (16%)

37 (19%)

0.4313

RB1

38 (18%)

21 (11%)

0.0478

KMT2C

29 (14%)

29 (15%)

0.7787

HMCN1

33 (16%)

25 (13%)

0.4780

FGFR3

8 (4%)

47 (24%)

 < 0.0001

RYR2

23 (11%)

33 (17%)

0.1124

MACF1

27 (13%)

27 (14%)

0.8838

EP300

31 (15%)

23 (12%)

0.3842

FLG

31 (15%)

21 (11%)

0.2376

FAT4

33 (16%)

18 (9%)

0.0520

STAG2

21 (10%)

27 (14%)

0.2820

ATM

25 (12%)

21 (11%)

0.7554

OBSCN

19 (9%)

27 (14%)

0.1586